Schedule 13G ownership disclosure

Nexvet Biopharma plc

Security class unavailable · CUSIP: G6503X109

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
459,135
Percent of class
4.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-16-000616
Form type
SC 13G/A
Filer
Nexvet Biopharma plc
CIK
CIK 1618561
Filed
Jan 11, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub